ArcticZymes is a public (OSE:AZT) biotech company focused on the development, manufacturing, and commercialisation of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and Advanced Therapies biomanufacturing.

Pre Diagnostics AS is a Norwegian biotech company developing biomarkers for neurodegenerative diseases. The disease areas in focus are Alzheimer's and Parkinson's. The biomarkers can be applied for clinical diagnostic and drug development purposes.

Wieslab AB is a subsidiary of SVAR Life Science. SVAR develops and markets immunoassays and cell-based solutions for drug development and clinical diagnostics. Responsible for leading the subsidiary Wieslab AB a contract laboratory organisation (CRO) and reporting to COB / CEO. Wieslab provides laboratory services globally within clinical diagnostic services to hospitals/labs as well as outsourced Bioanalytical pre-clinical and clinical trial services (PK, PD, TK, immunogenicity, QC lot release testing) for the biopharmaceutical industry. P&L responsibility and responsibility for sales & marketing, client relationship management, MSA negotiations, laboratory operations, business development and portfolio offering. Budgeting and financial planning. Test Site Management. • Revenue growth - 52 MSEK to 61 MSEK • 4 direct reports in management team and 32 people in organisation• Implementation of GMP laboratory operation offering QC lot release testing• Development and leadership of direct reports and organization • Implementation of ISO 15189 for medical laboratories and new laboratory IT infrastructure (LIMS)

Leadership and development of business. P&L and business planing responsibility. Leadership of sales & marketing, laboratory operations, business development and portfolio offering. Definition and execution of the sales strategy. Champion the development and delivery of client requested RFIs and RFPs. Test Site Management and part of SVAR Executive Management.• Revenue growth: 14 MSEK to 52 MSEK • 3 direct reports and from 10 to 32 employees in organisation • Leading and transforming the company to a more responsive and market driven contract service organisation. P&L responsibility. Scale up of organisation and providing leadership• Development and execution of strategy to go from a Scandinavia to global supplier of contract laboratory services. • Acquisition and integration support of Biomonitor A/S including merging of two laboratories from Denmark to Sweden. • Establishment and development of biopharma bioanalytical services business unit from the ground up - establishment of a GLP / GCP compliant laboratory organization with qualified staff.• Developed strategic alliances with partners in US and Europe to expand diagnostic test portfolio

General management of Wieslab clinical Diagnostic Services - a commercial private laboratory organisation focused on providing autoimmune disease specialty testing (immunoassays) for labs and clinicians within neurology, rheumatology and nephrology. P&L management. General marketing and sales management within the business unit.Focus areas: Internationalization. Establishing clinical diagnostic testing services in Sweden, Finland, Norway and Denmark• Revenue growth from 11 MSEK 14 MSEK• 2 Direct reports and 10 FTEs in organisation

Commercial management. Maximising profitability and revenue within the business unit and driving all commercial activities for Wieslab Clinical Diagnostic Services - Business development, Marketing and Sales. Tenders, proposals and contract negotiation. Secure new client relationships in order to expand client base, build awareness. Develop and maintain long-term client relationships to ensure repeat business. Patient community relationship building and engagement. • Conceptualization and launch of new website (UK + SE)• Establishment of KOL advisory board

Dako's high-quality diagnostic antibodies, reagents, instruments, software and expertise help hospitals and research labs around the world deliver accurate results to cancer patients.Managing globally the full product life cycle within the IVD primary staining portfolio consisting of instrumentation, software and reagents for tissue-based cancer diagnostics. Definition of new products, technologies and services. Interface with supply chain, R&D and Manufacturing to develop new products or enhance existing product(s) or product line(s) within the primary staining portfolio. Development and execution of marketing activities and assessment of changing market dynamics and competitive activity to maximize sales, market share, and profitability. Engagement in strategic planning, life-cycle management, oversight of the product portfolios tactical plan, including program development, branding, advertising, and sales support materials. B2B marketing.

Product management of tissue-based cancer diagnostics solutions including reagents, instruments and software. Responsible for commercial product development, product specification and marketing globally.

Oticon is part of Demant A/S, one of the largest hearing aid manufacturers in the world. The Oticon brand is known for leading-edge technology backed by extensive research from its Centre for Applied Audiology Research.International Product Manager for a number of successful hearing device product lines. Responsible for commercial development, product specification, launch and brand strategy. Worked closely with Field Marketing, Country Managers and the distributors to support the sales process. B2B and B2C marketing.

Marketing Coordinator with a focus on product marketing. Involvement in product development and subsequent marketing strategy development. Provided sales subsidiaries with ongoing marketing support to secure successful product launches. Development of sales promotions and brand maintenance activities. B2B and B2C marketing.

Marketing of disposables for Intensive Care Units and Operating Theatres. Development/maintenance of online sales and product training, marketing support for sales subsidiaries, market/competitor analysis.